Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q4 EPS of ($0.05), in-line with the analyst estimate of ($0.05).

For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.